Details of the Drug

General Information of Drug (ID: DMRQ0WD)

Drug Name

DS-1062

Synonyms

AUTFGCQEAOOQAR-UHFFFAOYSA-N; ethyl 5-(chloromethyl)-1,2,4-oxadiazole-3-carboxylate; 1009620-97-6; ethyl5-(chloromethyl)-1,2,4-oxadiazole-3-carboxylate; SCHEMBL3214456; KS-00000HYY; CTK3J9399; DTXSID80654863; MolPort-009-199-811; ZINC43220516; CE-804; ANW-49321; SBB091191; AKOS005146382; RP25017; CJ-20372; SC-14657; BR-40600; AN-25976; TC-061709; KB-202058; DB-026590; AJ-108509; KB-111885; AB0001145; FT-0083498; 4CH-008814; X8538; ST24030632; FT-0651464; AM20070658; S-5410; A15053; J-521069; ethyl 5-chloromethyl [1,2,4]oxadiazole-3-carboxylate; I14-10208; Ethyl 5

Indication

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C6H7ClN2O3
Canonical SMILES: CCOC(=O)C1=NOC(=N1)CCl
InChI: 1S/C6H7ClN2O3/c1-2-11-6(10)5-8-4(3-7)12-9-5/h2-3H2,1H3
InChIKey: AUTFGCQEAOOQAR-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 42605226
CAS Number: 1009620-97-6
TTD ID: D0E0YW

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)